Return To The Previous Page
Buy a Package
Number Of Visible Items Remaining : 3 Item

Rapid overview for hypoglycemia in adults, other than significant sulfonylurea overdose

Rapid overview for hypoglycemia in adults, other than significant sulfonylurea overdose
Clinical features
  • Any patient with acute change in mental status or coma should undergo rapid assessment of blood glucose as a possible cause.
  • All findings of hypoglycemia are nonspecific, including the following:
    • Autonomic response (tends to occur with blood glucose below 65 mg/dL)
      • Sweating
      • Weakness
      • Tachycardia
      • Palpitations
      • Tremor
      • Nervousness
      • Hunger
      • Paresthesias
    • Neuroglycopenia
      • Irritability
      • Confusion
      • Uncharacteristic behavior
      • Seizure
      • Occasionally, transient focal neurologic deficits
      • Loss of consciousness
      • Visual disturbance
Diagnostic evaluation
  • Obtain blood glucose concentration as soon as possible (usually with a meter and strips, if available):
    • For symptomatic patient known to have diabetes and with a low glucose value (<70 mg/dL [3.89 mmol/L]), administer treatment. If a glucose test cannot be performed, do not delay. Treat as if hypoglycemia has been confirmed.
    • If the glucose is low (<55 mg/dL) and the patient does not have diabetes, draw blood for glucose, insulin, C-peptide, and an oral hypoglycemic agent screen, and then treat.
  • Do not delay treatment if symptomatic hypoglycemia is suspected but rapid blood glucose measurement is not available or blood for diagnostic studies cannot be collected.
Treatment
  • If the patient is conscious and able to drink and swallow safely (ie, alert enough to do so and with gag reflex intact), administer a rapidly absorbed carbohydrate (eg, 3 to 4 glucose tablets or a tube of gel with 15 grams, 4 to 6 oz fruit juice or non-diet soda, or a teaspoon of honey or table sugar).*
  • If the patient has altered mental status, is unable to swallow, or does not respond to oral glucose administration within 15 minutes, give an IV bolus of 12.5 to 25 g of glucose (25 to 50 mL of 50% dextrose).
  • Measure a blood glucose 10 to 15 minutes after the IV bolus. Re-administer 12.5 to 25 grams of glucose as needed to maintain the blood glucose above 80 mg/dL.
  • If glucose cannot be given by parenteral or oral routes, give glucagon 1 mg IM or subcutaneously. Response may be transient and should be followed by careful glucose monitoring and oral or IV glucose administration.
  • Give additional maintenance glucose by mouth or IV. IV dextrose infusion should ensure delivery of 6 to 9 mg/kg per minute of glucose. Amounts needed vary depending upon the cause and severity of the symptomatic hypoglycemia. Once the patient is able to ingest carbohydrate safely, providing a mixed meal (including carbohydrates, such as a sandwich) is the preferred means of maintaining glucose levels.
  • Measure a blood glucose 10 to 15 minutes after the initial IV bolus and monitor every 30 to 60 minutes thereafter until stable (minimum of 4 hours). The measurement method should provide rapid turnaround, preferably at the point of care.
  • Admit patients with ingestion of a long-acting hypoglycemic agent, recurrent hypoglycemia during observation, and those unable to eat.

IM: intramuscular; IV: intravenous.

* Patients taking an alpha-glucosidase inhibitor (eg, acarbose, miglitol, voglibose) with symptomatic hypoglycemia should only receive pure glucose (dextrose) orally because digestion and absorption of other carbohydrates (eg, table sugar [sucrose]) will be delayed by these medications and will be less effective in raising blood glucose levels.
Graphic 73797 Version 6.0

Do you want to add Medilib to your home screen?